Listen on SoundCloud
Listen on iTunes
Via RSS feed
Published on 28/06/2018
Professor David Huang - 2018 ATSE Clunies Ross Knowledge Commercialisation Awardee
Professor David Huang, Associate Professor Peter Czabotar, Associate Professor Guillaume Lessene and Professor Andrew Roberts are recognised for their role in the development of a novel, potent anti-cancer drug called venetoclax. The drug was recently approved for use in the US, Europe and Australia to treat certain forms of chronic lymphocytic leukaemia (CLL).
Published on 26/06/2018
Dr Jim Aylward - 2018 ATSE Clunies Ross Innovation Awardee
Dr James Aylward is the inventor of Picato, a novel anti-skin cancer drug developed from a folklore remedy that has been used to treat more than one million patients. Picato is a prescription drug with worldwide sales and major competitive advantages, and has become part of the arsenal for dermatology clinics.
Published on 22/06/2018
Dr Rosalind Dubs FTSE - Former Chair of the Australian Space Industry Innovation Council
Our podcast with Dr Rosalind Dubs FTSE discusses why women are a minority in STEM jobs, why STEM skills are so important and how to increase the number of women in leadership roles.
Published on 18/06/2018
Dr Erol Harvey FTSE - 2018 ATSE Clunies Ross Entrepreneur of the Year
Scientist, educator and entrepreneur Dr Erol Harvey has made outstanding contributions to Australia through the world-leading microfluidic engineering company MiniFAB, his distinguished academic career and his unwavering support for research commercialisation
Promoting Australia's advancement through technology